Go back to News
NEWS
Gómez Acebo & Pombo closes 2022 with 10% growth in Spain
Gómez-Acebo & Pombo closes 2023 with a net turnover of almost 84 million euros (€ 83.83,000M) in fiscal year 2022, which represents a growth of 10%on the previous year’s turnover and an all-time high in the Firm’s turnover. In Spain, net revenues exceeded 75 million euros (€ 75.17 M) for the first time, representing an increase of 9.8% from the previous year.
At the practice area level, Corporate & Commercial represents 31% of total revenues. Banking, Capital Markets & Insurance, in turn, represents 15%, so that together the areas with the highest levels of transactions account for almost half of the Firm’s turnover, having grown by more than 11% with respect to the previous period. The other practice areas have also performed very favourably during the year. This is the case of Public Law, with a very remarkable growth, or Tax, Intellectual Property and Criminal Law, all of them with growth also above 10%.
In terms of offices, although all of them have performed well, billing is mainly concentrated in Madrid, which represents 75% of total billing in Spain. Lisbon, on the other hand, accounts for 9% of total billings.
Partner Iñigo Erlaiz says: “We are very satisfied with the results achieved. Growth is not an objective in itself but, together with other relevant indicators, it is evidence that we are on the right path to achieve our true objective of positioning ourselves as a benchmark firm in each and every one of our practice areas. The project is one of positioning, which is why we are also satisfied with the improvements in directories achieved during the year and with our outstanding position in the transaction rankings, both in terms of number and volume of transactions advised. It is a quiet and healthy growth, essentially organic and due to the advice we provide linked to higher value-added matters, rather than to an increase in headcount”.
Finally, Iñigo Erlaiz emphasizes that “Quality is the essential vector of the project. This year we have also launched various initiatives aimed at improving the organization’s productivity and efficiency in order to provide a better service to our clients. All this without losing our essence, in which proximity and the personal touch are differentiating factors that we continue to nurture”.
At the practice area level, Corporate & Commercial represents 31% of total revenues. Banking, Capital Markets & Insurance, in turn, represents 15%, so that together the areas with the highest levels of transactions account for almost half of the Firm’s turnover, having grown by more than 11% with respect to the previous period. The other practice areas have also performed very favourably during the year. This is the case of Public Law, with a very remarkable growth, or Tax, Intellectual Property and Criminal Law, all of them with growth also above 10%.
In terms of offices, although all of them have performed well, billing is mainly concentrated in Madrid, which represents 75% of total billing in Spain. Lisbon, on the other hand, accounts for 9% of total billings.
Partner Iñigo Erlaiz says: “We are very satisfied with the results achieved. Growth is not an objective in itself but, together with other relevant indicators, it is evidence that we are on the right path to achieve our true objective of positioning ourselves as a benchmark firm in each and every one of our practice areas. The project is one of positioning, which is why we are also satisfied with the improvements in directories achieved during the year and with our outstanding position in the transaction rankings, both in terms of number and volume of transactions advised. It is a quiet and healthy growth, essentially organic and due to the advice we provide linked to higher value-added matters, rather than to an increase in headcount”.
Finally, Iñigo Erlaiz emphasizes that “Quality is the essential vector of the project. This year we have also launched various initiatives aimed at improving the organization’s productivity and efficiency in order to provide a better service to our clients. All this without losing our essence, in which proximity and the personal touch are differentiating factors that we continue to nurture”.
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
2 days ago
Compensation for ‘loss of chance’ to reorganise the company had the banks fulfilled their financing commitments (Supreme Court (First Chamber) Judgment no. 1944/2025 of 23 December)
The Supreme Court applies compensation for loss of chance a second time outside the scope of healthcare liability and goes so far as to compensate cases that would have otherwise remained uncompensated.
PUBLICATION
3 days ago
European reform of the sustainability reporting regime under Directive (EU) 2026/470: consequences of its non-transposition into domestic law
Directive (EU) 2026/470 (Omnibus I) has been published, limiting the obligation to prepare a sustainability report to public-interest entities with more than 1,000 employees and a net turnover of more than €450 million during the preceding financial year, as well as to parent companies of a large group that exceed these figures on a consolidated basis. The Directive amends the audit directive, the accounting directive, the corporate sustainability reporting directive (CSRD) and the corporate sustainability due diligence directive (CSDDD).
PUBLICATION
4 days ago
Uncertificated share pledge creation, enforceability and avoidance (Supreme Court Judgment no.183/2026 of 10 February)
In Judgment no. 183/2026, of 10 February, the Supreme Court analysed the requirements for the validity and enforceability of an uncertificated registered share pledge and examined the conditions for its avoidance in the context of insolvency proceedings.
PUBLICATION
06 Mar, 2026
The long arm of the Unified Patent Court based on the "event giving rise to the infringement" and considerations on the application of lex loci protectionis
This paper analyses the decision of the Mannheim Local Division of 2 October 2025, where the Unified Patent Court (UPC) justifies its jurisdiction on the basis of shipment of products from a UPC territory by company listed as authorized representative in the EC and UK markets as event giving rise to damage. Furthermore, although the applicable law with regard to the infringement of the European patent validated in States that are not party to the Agreement on a Unified Patent Court is the national law of those States, with regard to the scope of patent protection, the UPC imposes on the defendant—unduly—the burden of proving the specifics of national law.
PUBLICATION
03 Mar, 2026
Legal doctrine of the UPC’s Court of Appeal on the patent invalidity defence: is the way in which the ‘long arm’ is applied compatible with the UPC's own Rules of Procedure?
The Court of Appeal of the Unified Patent Court has ruled that a patent invalidity defence cannot be raised before the Unified Patent Court, with only a counterclaim being possible. This calls into question the way in which the ‘long arm’ is being applied with regard to European patents validated in States that are not party to the Agreement on a Unified Patent Court (UPCA), whether or not they are members of the European Union, since no counterclaim for revocation or plea of invalidity as a defence can be filed or raised with regard to such patents. This raises significant doubts about the compatibility of how the ‘long arm’ is applied in the Unified Patent Court system, given its own Rules of Procedure.
PUBLICATION
26 Feb, 2026
A restructuring plan sanctioned in England and Wales that modifies debt subject to German law has no effect in Germany
Recognition of UK restructuring plans remains a contentious issue in the European Union. This decision by the Frankfurt am Main Regional Court is controversial, but it raises questions about the consequences of the application of the rule in Gibbs by the courts of England and Wales in this context.
PUBLICATION
26 Feb, 2026
Pharma & Healthcare No. 47
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
23 Feb, 2026
Irregularities in public sector staffing. Jurisdiction and/or substantive law
When a serious irregularity is found in administrative contracts owing to their employment character, jurisdiction lies with the employment branch of the court system. However, if the administrative route is not outside the scope of the law, jurisdiction lies with the judicial review branch of the court system.
PUBLICATION
17 Feb, 2026
Squeeze-out of minority shareholders following successful mandatory takeover bid: rebuttable presumption of fair consideration
The Court of Justice of the European Union (Fifth Chamber), in its judgment of 27 November 2025 (Case C-567/24, Svema Trade), concerning the equitable price in a squeeze-out requiring minority shareholders to sell their shares to an offeror who, following a mandatory takeover bid, has acquired more than 90% of the capital carrying voting rights in the company subject of the takeover bid, states that the presumption that the price offered in the bid, in the context of such a squeeze-out of holders of securities, is equitable is rebuttable.